Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2025 Earnings Call Transcript August 7, 2025
Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.99, expectations were $-1.03.
Operator: Good morning, and welcome to Intellia Therapeutics Second Quarter 2025 Financial Results Conference Call. My name is Drew, and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded...
